Cue Biopharma, Inc.CUENASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-21.86M
↑ 25% vs avg
Percentile
P70
Within normal range
Streak
3 yr
Consecutive growthExpanding
Average
$-29.20M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-21.86M | +39.9% |
| 2024 | $-36.40M | +8.9% |
| 2023 | $-39.96M | +4.8% |
| 2022 | $-41.98M | -5.6% |
| 2021 | $-39.75M | -20.1% |
| 2020 | $-33.09M | -7.3% |
| 2019 | $-30.84M | -9.1% |
| 2018 | $-28.27M | -111.0% |
| 2017 | $-13.40M | -106.6% |
| 2016 | $-6.48M | - |